Reviewing DSV A/S (OTCMKTS:DSDVF) and Cryoport (NASDAQ:CYRX)
Posted by MarketBeat News on Oct 1st, 2023
DSV A/S (OTCMKTS:DSDVF – Get Free Report) and Cryoport (NASDAQ:CYRX – Get Free Report) are both industrials companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability.
Institutional and Insider Ownership
31.5% of DSV A/S shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 10.5% of Cryoport shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for DSV A/S and Cryoport, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DSV A/S | 1 | 2 | 1 | 0 | 2.00 |
| Cryoport | 0 | 5 | 3 | 0 | 2.38 |
Want More Great Investing Ideas?
- 10 Stocks to Sell NOW!
- 3 Stocks to DOUBLE This Year
- The 10 Best Stocks to Own in 2023
- 7 Stocks to Buy and Hold Forever
Cryoport has a consensus target price of $20.78, indicating a potential upside of 51.55%. Given Cryoport’s stronger consensus rating and higher probable upside, analysts clearly believe Cryoport is more favorable than DSV A/S.
Profitability
This table compares DSV A/S and Cryoport’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DSV A/S | N/A | N/A | N/A |
| Cryoport | -16.07% | -7.23% | -3.73% |
Earnings and Valuation
This table compares DSV A/S and Cryoport’s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DSV A/S | N/A | N/A | N/A | $8.38 | 21.93 |
| Cryoport | $237.28 million | 2.82 | -$37.33 million | ($0.97) | -14.13 |
DSV A/S has higher earnings, but lower revenue than Cryoport. Cryoport is trading at a lower price-to-earnings ratio than DSV A/S, indicating that it is currently the more affordable of the two stocks.
Summary
Cryoport beats DSV A/S on 6 of the 11 factors compared between the two stocks.
About DSV A/S
DSV A/S offers transport and logistics services in Europe, the Middle East, Africa, North America, South America, Asia, Australia, and the Pacific. It operates through three segments: Air & Sea, Road, and Solutions. The company provides air freight, air freight compliance and carrier, and rail freight services; sea freight, and sea freight compliance and carrier services, as well as freight containers. It also offers road freight services, such as part and full loads, groupage, specialized transport, express, and online and document handling services; and workshops. In addition, the company provides logistics solutions for automotive, consumer products, healthcare, high-tech, and industrial sectors; and inventory management solutions. Further, it offers special project transport services, such as industrial projects, renewable energy, government logistics, ship charter, and air charter services; and courier and warehousing services. The company was formerly known as DSV Panalpina A/S and changed its name to DSV A/S in September 2021. DSV A/S was incorporated in 1976 and is based in Hedehusene, Denmark.
About Cryoport
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Receive News & Ratings for DSV A/S Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DSV A/S and related companies with MarketBeat.com's FREE daily email newsletter.
You might be interested in:
UiPath Given “Sector Perform” Rating at Royal Bank of Canada
StockNews.com Begins Coverage on Retractable Technologies
Barclays Lowers Pinnacle West Capital Price Target to $77.00
Needham & Company LLC Reaffirms Buy Rating for PROS
Robert Half Rating Increased to Buy at StockNews.com
Safeguard Scientifics Receives New Coverage from Analysts at StockNews.com



